<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2018.83060</article-id><article-id pub-id-type="publisher-id">ACM-25026</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20180300000_79889684.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  血尿酸与阿尔茨海默病关系的Meta分析
  Association between Serum Uric Acid Levels and Alzheimer’s Disease: A Meta Analysis
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>雨涵</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>来霞</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>杨</surname><given-names>金红</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>刘</surname><given-names>聿秀</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff5"><addr-line>潍坊医学院护理学院，山东 潍坊</addr-line></aff><aff id="aff2"><addr-line>潍坊医学院临床医学院，山东 潍坊</addr-line></aff><aff id="aff3"><addr-line>潍坊医学院附属医院，山东 潍坊</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><aff id="aff4"><addr-line>潍坊市人民医院肿瘤科，山东 潍坊</addr-line></aff><pub-date pub-type="epub"><day>17</day><month>05</month><year>2018</year></pub-date><volume>08</volume><issue>03</issue><fpage>356</fpage><lpage>365</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    目的：系统评价血尿酸在阿尔茨海默病患者和一般人群之间的差异，探讨血尿酸与阿尔茨海默病之间的关系。方法：计算机检索PubMed、EMbase、The Cochrane Library、CNKI、CBM、维普、万方数据库，并辅以参考文献追溯和手工检索方法，查找有关血尿酸水平与阿尔茨海默病的病例–对照研究的文献，检索时限均为建库时间至2017年8月。由两位评价员按照纳入与排除标准独立筛选文献、提取资料和质量评价后，采用stata12.0软件进行统计量的合并分析。结果：最终纳入24个研究，共计1378例阿尔茨海默病患者。Meta分析结果为SMD = −0.27，95% CI (−1.16, −1.28)，P &lt; 0.001，说明病例组的血尿酸水平低于对照组，病例组与对照组之间血尿酸的差异有统计学意义。亚组分析显示各个研究的异质性可能来源于尿酸的测定方法。敏感性分析显示各个研究之间的结果较稳定，Meta分析的结果较稳健。经Begger’s和Egger’s检验，P &gt; 0.1，提示无发表偏倚。结论：阿尔茨海默病患者的血尿酸水平较一般人群低，提示血尿酸水平较高患阿尔茨海默病的风险相对较低，血尿酸较高是阿尔茨海默病的保护因素。
    Objective: To systematically evaluate the difference of serum uric acid between patients with Alz-heimer’s disease and the general population and to explore the relationship between serum uric acid and Alzheimer’s disease. Methods: We searched PubMed, EMbase, The Cochrane Library, CNKI, CBM, VIP, Wanfang database, traced back to reference documentation and used manual retrieval method, in order to find out case-control study on the level of serum uric acid and Alzheimer’s disease. Retrieval time limitation is from inception to August 2017. Two reviewers screened articles, extracted data and evaluated quality independently according to inclusion and exclusion criteria. The analysis of statistical data was performed using stata12.0 software. Results: 24 studies were included, with a total of 1378 patients with Alzheimer’s disease. The results of Meta analysis were SMD = −0.27, 95%CI (−1.16, −1.28), P &lt; 0.001, indicating that the level of serum uric acid in the case group was lower than that in the control group, and the difference of serum uric acid between the case group and the control group was statistically significant. Subgroup analysis showed that heterogeneity in each study may be due to the measuring method of serum uric acid. Sensitivity analysis showed that the results of each study were stable, and the results of Meta analysis were robust. Results of Begger’s and Egger’s test were both P &gt; 0.1, suggesting no publication bias. Conclusion: The level of serum uric acid in patients with Alzheimer’s disease is lower than that of the general population, suggesting that the high level of serum uric acid reduce the risk of Alz-heimer’s disease relatively. 
  
 
</p></abstract><kwd-group><kwd>尿酸，阿尔茨海默病，病例对照研究，Meta分析, Uric Acid</kwd><kwd> Alzheimer’s Disease</kwd><kwd> Case Control Study</kwd><kwd> Meta Analysis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>血尿酸与阿尔茨海默病关系的Meta分析<sup> </sup></title><p>王雨涵<sup>1</sup>，张来霞<sup>2</sup>，杨金红<sup>3</sup>，刘聿秀<sup>4*</sup></p><p><sup>1</sup>潍坊医学院临床医学院，山东 潍坊</p><p><sup>2</sup>潍坊医学院附属医院，山东 潍坊</p><p><sup>3</sup>潍坊市人民医院肿瘤科，山东 潍坊</p><p><sup>4</sup>潍坊医学院护理学院，山东 潍坊</p><disp-formula id="hanspub.25026-formula7"><graphic xlink:href="//html.hanspub.org/file/15-1570527x5_hanspub.png"  xlink:type="simple"/></disp-formula><p>收稿日期：2018年4月29日；录用日期：2018年5月17日；发布日期：2018年5月24日</p><disp-formula id="hanspub.25026-formula8"><graphic xlink:href="//html.hanspub.org/file/15-1570527x6_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>目的：系统评价血尿酸在阿尔茨海默病患者和一般人群之间的差异，探讨血尿酸与阿尔茨海默病之间的关系。方法：计算机检索PubMed、EMbase、The Cochrane Library、CNKI、CBM、维普、万方数据库，并辅以参考文献追溯和手工检索方法，查找有关血尿酸水平与阿尔茨海默病的病例–对照研究的文献，检索时限均为建库时间至2017年8月。由两位评价员按照纳入与排除标准独立筛选文献、提取资料和质量评价后，采用stata12.0软件进行统计量的合并分析。结果：最终纳入24个研究，共计1378例阿尔茨海默病患者。Meta分析结果为SMD = −0.27，95% CI (−1.16, −1.28)，P &lt; 0.001，说明病例组的血尿酸水平低于对照组，病例组与对照组之间血尿酸的差异有统计学意义。亚组分析显示各个研究的异质性可能来源于尿酸的测定方法。敏感性分析显示各个研究之间的结果较稳定，Meta分析的结果较稳健。经Begger’s和Egger’s检验，P &gt; 0.1，提示无发表偏倚。结论：阿尔茨海默病患者的血尿酸水平较一般人群低，提示血尿酸水平较高患阿尔茨海默病的风险相对较低，血尿酸较高是阿尔茨海默病的保护因素。</p><p>关键词 :尿酸，阿尔茨海默病，病例对照研究，Meta分析</p><disp-formula id="hanspub.25026-formula9"><graphic xlink:href="//html.hanspub.org/file/15-1570527x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2018 by authors and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/15-1570527x8_hanspub.png" /> <img src="//html.hanspub.org/file/15-1570527x9_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>阿尔茨海默病(Alzheimer’s disease, AD)是一种神经系统退行性疾病，是老年痴呆中最常见的类型 [<xref ref-type="bibr" rid="hanspub.25026-ref1">1</xref>] ，主要表现为逐渐加重的认知功能损害和日常生活能力下降。随着人口老龄化的进展，阿尔茨海默病的发病率明显升高，严重威胁人们的健康 [<xref ref-type="bibr" rid="hanspub.25026-ref2">2</xref>] 。2015年世界阿尔茨海默病报告显示，全球大约每3秒就有1例痴呆患者被确诊，预计2050年全球老年痴呆的人数将由4600万人增加至1.315亿 [<xref ref-type="bibr" rid="hanspub.25026-ref3">3</xref>] 。AD的病理特征包括β淀粉样蛋白沉积、老年斑形成、神经元纤维缠结形成以及突触丧失、神经元丢失等。目前，关于阿尔茨海默病的确切发病机制尚不清楚 [<xref ref-type="bibr" rid="hanspub.25026-ref4">4</xref>] 。近年来，氧化应激及自由基损伤学说受到研究者的关注，在一定程度上综合了其他几种假说，可以认为氧化应激贯穿于AD发生、发展的整个过程。在氧化应激学说中，AD神经病理主要与自由基生成与清除之间的不平衡有关 [<xref ref-type="bibr" rid="hanspub.25026-ref5">5</xref>] 。人体内存在抗氧化剂—促氧化剂尿酸盐氧化还原系统，血尿酸在一定范围内具有抗氧化特性，具有清除氧自由基和其他活性自由基的保护作用；但血尿酸水平过高时，尿酸变得具有促氧化特性，便成为致病因素 [<xref ref-type="bibr" rid="hanspub.25026-ref6">6</xref>] 。</p><p>在黄德弘 [<xref ref-type="bibr" rid="hanspub.25026-ref7">7</xref>] 、Cervellati [<xref ref-type="bibr" rid="hanspub.25026-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.25026-ref9">9</xref>] 的研究中阿尔茨海默病患者血尿酸水平高于对照人群，而在Cankurtaran [<xref ref-type="bibr" rid="hanspub.25026-ref10">10</xref>] 、Baldeirasa [<xref ref-type="bibr" rid="hanspub.25026-ref11">11</xref>] 等的研究中阿尔茨海默病患者的血尿酸水平比对照人群低。所以血清尿酸水平是阿尔茨海默病的保护因素还是危险因素仍存在争议，考虑到这些研究结果的不一致性，本文通过系统评价血尿酸水平与阿尔茨海默病的关系，为临床预防与治疗提供参考。</p></sec><sec id="s4"><title>2. 材料与方法</title><p>一、资料来源和检索策略</p><p>计算机检索PubMed、EMbase、The Cochrane Library、CNKI、CBM、维普、万方数据库，并辅以参考文献追溯和手工检索方法。英文检索词包括(uric acid OR urate) AND ( Alzheimer’s disease)，中文检索词包括尿酸、阿尔茨海默病。文献发表时间为各数据库建库时间至2017年8月，语种限中英文。</p><p>二、文献纳入与排除标准</p><p>纳入标准：1) 研究对象为阿尔茨海默病患者和一般人群；2) 研究设计为病例—对照研究；3) AD诊断标准符合DSM-IV或DSM-III和(或)NINCDS-ADRDA标准 [<xref ref-type="bibr" rid="hanspub.25026-ref3">3</xref>] ；4) 暴露因素明确说明实验室中血尿酸的检测方法；5) 结局指标提供均数、标准差等指标分析血尿酸在病例组和对照组间的差异，或者提供均数、样本量、95%可信区间可通过公式转换得到标准差。排除标准：1) 对照组为患有其它非AD类型的老年痴呆的病人；2) 重复研究；3) 数据不可靠或无法提取数据；4) 未明确说明AD的诊断标准。</p><p>三、文献筛选及资料提取</p><p>由两位评价员独立阅读筛选文献，首先阅读文献的题目和摘要，排除部分明显不相关的文献，之后阅读全文提取资料并交叉核对，双方出现分歧时经讨论解决，必要时由第三位研究者进行裁定。资料提取内容包括第一作者，研究所在国家，文献发表年份，病例组和对照组的例数、性别比例(男/女)、年龄(均数 &#177; 标准差)、血尿酸(均数 &#177; 标准差)、阿尔茨海默病诊断标准。由于纳入的文献中血尿酸单位不一致，统一换算成以mg/dl为单位，1 mg/dl = 59.52 umol/l。</p><p>四、文献质量评价</p><p>采用非随机研究偏倚风险评估方法纽卡斯尔-渥太华量表(Newcastle-Ottawa scale, NOS)，对纳入研究的偏倚风险进行评估，从病例组与对照组选择方法、可比性、暴露三方面进行质量评价。NOS量表共8个条目，9分，将评分 ≥ 6分的文献纳入研究。</p><p>五、统计分析</p><p>采用Excel软件在数据提取表上进行数据录入。采用Stata 12.0软件进行meta分析。各研究结果间的异质性采用χ<sup>2</sup>检验分析，检验水准为α = 0.1，并采用I<sup>2</sup>衡量异质性的大小。当各研究结果间P &gt; 0.1，I<sup>2</sup> &lt; 50%时，可认为各研究结果间具有同质性时，使用固定效应模型进行分析；当各研究结果P ≤ 0.1，I<sup>2</sup> ≥ 50%，说明各研究结果间存在异质性时，则使用随机效应模型进行分析。P ≤ 0.1，I<sup>2</sup> ≥ 50%时，根据可能导致异质性的因素(如种族等)进行亚组分析，从而分析异质性的来源。通过逐篇去除文献并观察异质性的变化进行敏感性分析，从而分析异质性的来源。通过Begger’s和Egger’s检验分析发表偏倚。</p></sec><sec id="s5"><title>3. 结果</title><p>一、文献检索结果</p><p>初检出相关文献2762篇，经逐层筛选后，最终纳入24个病例–对照研究 [<xref ref-type="bibr" rid="hanspub.25026-ref7">7</xref>] - [<xref ref-type="bibr" rid="hanspub.25026-ref30">30</xref>] ，共1378例阿尔茨海默病患者。其中中文文章8篇，英文文章16篇。文献筛选流程及结果见图1。纳入的病例–对照研究在亚洲进行的有13篇，其中中国8篇、土耳其2篇、韩国1篇、日本1篇、约旦1篇；在欧洲进行的有9篇，其中意大利5篇、德国2篇、西班牙1篇、葡萄牙1篇；在美国进行的有1篇；在非洲进行的有1篇。纳入研究的基本特征见表1。</p><p>二、纳入研究的质量评价</p><p>共纳入24篇研究，根据NOS量表进行评分，均在6~9之间。其中2篇9分、4篇8分、14篇7分、</p><p>图1. 文献筛选流程及结果</p><p>4篇6分，提示为较高质量的研究，质量评价结果见表2。</p><p>三、血尿酸与阿尔茨海默病Meta分析结果</p><p>1) 血尿酸与阿尔茨海默病Meta分析：结果显示SMD = −0.27，95% CI (−1.16, −1.28)，P &lt; 0.001，采用随机效应模型进行分析。说明阿尔茨海默病病例组的血尿酸水平低于对照组的血尿酸水平，病例组与对照组之间尿酸水平的差异有统计学意义。森林图见图2。</p><p>2) 亚组分析结果：由于Meta分析结果所显示的异质性较高(P &lt; 0.001, I<sup>2</sup> = 96.6%)，需分析异质性的来源。按研究对象所在的不同的洲分组进行亚组分析，分组后亚组内仍存在较大的异质性，欧洲组(P &lt; 0.001, I<sup>2</sup> = 98.3%)，但在亚洲组内的异质性有所减小(P &lt; 0.001, I<sup>2</sup> = 90.5%)。按尿酸测定方法分组，酶法组(P &lt; 0.001, I<sup>2</sup> = 98.6%)，比色法组(P &lt; 0.001, I<sup>2</sup> = 89.7%)，HPLC法组(P = 1.35, I<sup>2</sup> = 50%)。见图3、图4。</p><p>3) 敏感性分析：通过逐篇去除文献并观察剩余文献统计量合并后异质性的变化，发现每排除一篇研究后剩余研究合并的RR值均在总合并结果的95% CI内，说明各项研究结果之间较稳定，meta分析的结果较稳健。见图5。</p>

</sec>
  </body>

<back><ref-list><title>References</title><ref id="hanspub.25026-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Sarkar, A., Irwin, M., Singh, A., et al. (2016) Alzheimer’s Disease: The Silver Tsunami of the 21(st) Century. Neural Regeneration Research, 11, 693-697. https://doi.org/10.4103/1673-5374.182680</mixed-citation></ref><ref id="hanspub.25026-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Barnes, D.E. and Yaffe, K. (2011) The Projected Effect of Risk Factor Reduction on Alzheimer’s Disease Prevalence. The Lancet Neurology, 10, 819-828. https://doi.org/10.1016/S1474-4422(11)70072-2</mixed-citation></ref><ref id="hanspub.25026-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">袁俊亮, 杨淑娜, 陈宇丹, 等. 2016《中国血管性轻度认知损害诊断指南》解读[J]. 中华老年心脑血管病杂志, 2017(19): 108-110.</mixed-citation></ref><ref id="hanspub.25026-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Owen, J.B., Sultana, R., Aluise, C.D., et al. (2010) Oxidative Modification to LDL Receptor-Related Protein 1 in Hippocampus from Subjects with Alzheimer Disease: Implications for Aβ Accumulation in AD Brain. Free Radical Biology &amp; Medicine, 49, 1798-1803. https://doi.org/10.1016/j.freeradbiomed.2010.09.013</mixed-citation></ref><ref id="hanspub.25026-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Christen, Y. (2001) Oxidative Stress and Alzheimer Disease. The American Journal of Clinical Nutrition, 71, 621-629.  
https://doi.org/10.1093/ajcn/71.2.621s</mixed-citation></ref><ref id="hanspub.25026-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">杨南竹, 贠相华. 尿酸代谢异常与阿尔茨海默病关系的研究进展[J]. 医学综述, 2015, 21(14): 2572-2574.</mixed-citation></ref><ref id="hanspub.25026-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">黄德弘, 刘孟渊. 阿尔茨海默病和血管性痴呆患者血脂、血糖及尿酸水平的变化[J]. 广东医学, 2013, 34(4): 587-589.</mixed-citation></ref><ref id="hanspub.25026-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Cervellati, C., Cremonini, E., Bosi, C., et al. (2013) Systemic Oxidative Stress in Older Patients with Mild Cognitive Impairment or Late Onset Alzheimer’s Disease. Current Alzheimer Research, 10, 365-372.  
https://doi.org/10.2174/1567205011310040003</mixed-citation></ref><ref id="hanspub.25026-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Cervellati, C., Romani, A., Seripa, D., et al. (2014) Oxidative Balance, Homocysteine, and Uric Acid Levels in Older Patients with Late Onset Alzheimer’s Disease or Vascular Dementia. Journal of the Neurological Sciences, 337, 156-161. https://doi.org/10.1016/j.jns.2013.11.041</mixed-citation></ref><ref id="hanspub.25026-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Cankurtaran, M., Yesil, Y., Kuyumcu, M.E., et al. (2013) Altered Levels of Homocysteine and Serum Natural Antioxidants Links Oxidative Damage to Alzheimer’s Disease. Journal of Alzheimer’s Disease: JAD, 33, 1051-1058.</mixed-citation></ref><ref id="hanspub.25026-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Baldeiras, H., Santanab, I., Proenc, M.T., et al. (2008) Peripheral Ox-idative Damage in Mild Cognitive Impairment and Mild Alzheimer’s Disease. Journal of Alzheimer’s Disease, 15, 117-128. https://doi.org/10.3233/JAD-2008-15110</mixed-citation></ref><ref id="hanspub.25026-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Carantoni, M., Zuliani, G., Munari, M.R., et al. (2000) Alzheimer Disease and Vascular Dementia: Relationships with Fasting Glucose and Insulin Levels. Dementia and Geriatric Cognitive Disorders, 11, 176-180.  
https://doi.org/10.1159/000017232</mixed-citation></ref><ref id="hanspub.25026-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Rinaldi, P., Polidori, M.C., Metastasio, A., et al. (2003) Plasma Antiox-idants Are Similarly Depleted in Mild Cognitive Impairment and in Alzheimer’s Disease. Neurobiology of Aging, 24, 915-919.  
https://doi.org/10.1016/S0197-4580(03)00031-9</mixed-citation></ref><ref id="hanspub.25026-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Pulido, R., Jimenez-Escrig, A., Orensanz, L., et al. (2005) Study of Plasma Antioxidant Status in Alzheimer’s Disease. European Journal of Neurology, 12, 531-535. https://doi.org/10.1111/j.1468-1331.2005.01000.x</mixed-citation></ref><ref id="hanspub.25026-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Polidori, M.C., Mattioli, P., Aldred, S., et al. (2004) Plasma Antioxidant Status, Immunoglobulin g Oxidation and Lipid Peroxidation in Demented Patients: Relevance to Alzheimer Disease and Vascular Dementia. Dementia and Geriatric Cognitive Disorders, 18, 265-270. https://doi.org/10.1159/000080027</mixed-citation></ref><ref id="hanspub.25026-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Can, M., Varlibas, F., Guven, B., et al. (2013) Ischemia Modified Al-bumin and Plasma Oxidative Stress Markers in Alzheimer’s Disease. European Neurology, 69, 377-380. https://doi.org/10.1159/000339006</mixed-citation></ref><ref id="hanspub.25026-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Ramdane, S. (2011) Plasma Urate in Patients with Alzheimer’s Disease. Alzheimer’s and Dementia, 7, 153.  
https://doi.org/10.1016/j.jalz.2011.05.411</mixed-citation></ref><ref id="hanspub.25026-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Kim, T.S., Pae, C.U., Yoon, S.J., et al. (2006) Decreased Plasma Antioxidants in Patients with Alzheimer’s Disease. International Journal of Geriatric Psychiatry, 21, 344-348. https://doi.org/10.1002/gps.1469</mixed-citation></ref><ref id="hanspub.25026-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Maesaka, J.K., Wolf-Klein, G., Piccione, J.M., et al. (1993) Hypouricemia, Abnormal Renal Tubular Urate Transport, and Plasma Natriuretic Factor(s) in Patients with Alzheimer’s Disease. Journal of the American Geriatrics Society, 41, 501-506. https://doi.org/10.1111/j.1532-5415.1993.tb01885.x</mixed-citation></ref><ref id="hanspub.25026-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Al-Khateeb, E., Althaher, A., Al-Khateeb, M., et al. (2015) Relation between Uric Acid and Alzheimer’s Disease in Elderly Jordanians. Journal of Alzheimer’s Disease: JAD, 44, 859-865.</mixed-citation></ref><ref id="hanspub.25026-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Hatanaka, H., Hanyu, H., Fukasawa, R., et al. (2015) Differences in Peripheral Oxidative Stress Markers in Alzheimer’s Disease, Vascular Dementia and Mixed Dementia Patients. Geriatrics &amp; Gerontology International, 15, 53-58.  
https://doi.org/10.1111/ggi.12659</mixed-citation></ref><ref id="hanspub.25026-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Iulianoa, L., Monticoloa, R., Straface, G., et al. (2010) Vitamin E and Enzymatic/Oxidativestress-Driven Oxysterols in Amnestic Mildcognitive Impairment Subtypes and Alzheimer’s Disease. Journal of Alzheimer’s Disease, 21, 1383-1392. https://doi.org/10.3233/JAD-2010-100780</mixed-citation></ref><ref id="hanspub.25026-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Polidori, M.C. and Mecocci, P. (2002) Plasma Susceptibility to Free Radical Induced Antioxidant Consumption and Lipid Peroxidation Is Increased in Very Old Subjects with Alzheimer Disease. Journal of Alzheimer’s Disease, 4, 517-522. https://doi.org/10.3233/JAD-2002-4608</mixed-citation></ref><ref id="hanspub.25026-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">商秀丽, 张凤英, 孟令慧, 等. 阿尔茨海默病患者血尿酸水平的检测及意义[J]. 中国医科大学学报, 2009, 38(5): 333-334.</mixed-citation></ref><ref id="hanspub.25026-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">孙小康, 潘锋丰, 黄高忠, 等. 阿尔茨海默病患者认知功能与血尿酸水平的关系[J]. 老年医学与保健, 2013, 19(6): 380-382.</mixed-citation></ref><ref id="hanspub.25026-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">杨嘉辉. 阿尔茨海默病及血管性痴呆患者血尿酸检验结果分析[J]. 现代诊断与治疗, 2014(1): 161-162.</mixed-citation></ref><ref id="hanspub.25026-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">吴甜莺, 张雄, 郑永克, 等. 同型半胱氨酸、叶酸和尿酸在认知功能障碍诊断中的意义[J]. 温州医科大学学报, 2015(8): 608-611.</mixed-citation></ref><ref id="hanspub.25026-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">黄东明, 吕泽平, 覃少东, 等. 阿尔茨海默病尿酸水平相关性研究[J]. 广西医学, 2012, 34(11): 1483-1485.</mixed-citation></ref><ref id="hanspub.25026-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">王楠, 何远宏, 潘双杰, 等. 阿尔茨海默病患者认知功能及血清铜、同型半胱氨酸、尿酸水平、tau和Aβ1-42蛋白的检测[J]. 郑州大学学报(医学版), 2015, 50(3): 407-409.</mixed-citation></ref><ref id="hanspub.25026-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">周颖, 谭红, 王爱民, 等. 尿酸与阿尔茨海默病患者不同认知功能域的相关研究[J]. 中国医师杂志, 2012, 14(7): 904-906.</mixed-citation></ref><ref id="hanspub.25026-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">张琳琳, 宋宛珊, 王凯, 等. 阿尔茨海默病发病机制及药物治疗研究进展[J]. 世界中医药, 2017, 12(5): 1200-1208.</mixed-citation></ref><ref id="hanspub.25026-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">许桦, 肖世富. 阿尔茨海默病诊断和药物治疗新进展[J]. 中国神经精神疾病杂志, 2017, 43(6): 379-382.</mixed-citation></ref><ref id="hanspub.25026-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">刘云, 吴晓球. 老年痴呆症危险因素的研究进展[J]. 医学综述, 2016, 22(12): 2349-2352.</mixed-citation></ref></ref-list>

</back></article>